A Study of BNC210 in Elderly Patients With Agitation

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 17, 2018

Primary Completion Date

April 23, 2019

Study Completion Date

April 24, 2019

Conditions

Agitation in the Elderly

Interventions

DRUG

BNC210

BNC210 300 mg b.i.d

DRUG

Placebo

Placebo b.i.d.

Trial Locations (5)

Prince of Wales Hospital, Sydney

Modbury Hospital, Adelaide

Northern Health, Melbourne

Royal Melbourne Hospital, Melbourne

Western Health, Melbourne